FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2960101348> ?p ?o ?g. }

• W2960101348 abstract "Artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DHA/PPQ) are the recommended first- and second-line treatments, respectively, for uncomplicated falciparum malaria in Somalia. The studies reported here were conducted to assess the efficacy of these artemisinin-based combinations and the mutations in Plasmodium falciparum K13-propeller (Pfk13) domain and amplification in Pfplasmepsin 2 (Pfpm2) gene in Somalia.One-arm prospective studies were conducted to assess the clinical and parasitological responses to DHA/PPQ and AL at two sites in 2016 and 2017, respectively, using the standard WHO protocol. The patterns of molecular markers associated with artemisinin and PPQ resistance were investigated for the first time in Somalia.A total of 339 patients were enrolled with 139 for AL and 200 for DHA/PPQ. With AL, no parasite recurrence was observed among patients treated at either site, corresponding to 100% clinical and parasitological responses. For DHA-PPQ, an adequate clinical and parasitological response rate > 97% was observed. All study patients on both treatments at both sites were parasite-free on day 3. Of the 138 samples with interpretable results for the polymorphism in Pfk13, only one (0.7%), from Bosaso, contained a non-synonymous mutation (R622I), which is not one of the known markers of artemisinin resistance. No Pfpm2 amplification was observed among the 135 samples with interpretable results.AL and DHA/PPQ were highly effective in the treatment of uncomplicated falciparum malaria, and there was no evidence of resistance to artemisinin or PPQ. These two combinations are thus relevant in the chemotherapeutic strategy for malaria control in Somalia. Trial registration ACTRN12616001005448 (Jowhar DP study), ACTRN12616000553471 (Bosaso DP study), ACTRN12617001055392 (AL study in Bosaso and Jowhar)." @default.
• W2960101348 created "2019-07-23" @default.
• W2960101348 creator A5012199507 @default.
• W2960101348 creator A5012720550 @default.
• W2960101348 creator A5014087860 @default.
• W2960101348 creator A5024691862 @default.
• W2960101348 creator A5032947745 @default.
• W2960101348 creator A5042879380 @default.
• W2960101348 creator A5042900357 @default.
• W2960101348 creator A5049427727 @default.
• W2960101348 creator A5054399462 @default.
• W2960101348 creator A5063837509 @default.
• W2960101348 creator A5064218236 @default.
• W2960101348 creator A5064797479 @default.
• W2960101348 creator A5070525052 @default.
• W2960101348 creator A5083456572 @default.
• W2960101348 creator A5089661257 @default.
• W2960101348 date "2019-07-11" @default.
• W2960101348 modified "2023-10-18" @default.
• W2960101348 title "High therapeutic efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Somalia" @default.
• W2960101348 cites W1595974425 @default.
• W2960101348 cites W1816616281 @default.
• W2960101348 cites W2010067521 @default.
• W2960101348 cites W2013035959 @default.
• W2960101348 cites W2039200189 @default.
• W2960101348 cites W2041672057 @default.
• W2960101348 cites W2042116011 @default.
• W2960101348 cites W2102395543 @default.
• W2960101348 cites W2104700616 @default.
• W2960101348 cites W2105472483 @default.
• W2960101348 cites W2105812381 @default.
• W2960101348 cites W2108523891 @default.
• W2960101348 cites W2124634096 @default.
• W2960101348 cites W2130646906 @default.
• W2960101348 cites W2149251475 @default.
• W2960101348 cites W2155009848 @default.
• W2960101348 cites W2157261068 @default.
• W2960101348 cites W2165853589 @default.
• W2960101348 cites W2169329132 @default.
• W2960101348 cites W2171102256 @default.
• W2960101348 cites W2229864756 @default.
• W2960101348 cites W2291884573 @default.
• W2960101348 cites W2344626565 @default.
• W2960101348 cites W2415685063 @default.
• W2960101348 cites W2467259677 @default.
• W2960101348 cites W2515978767 @default.
• W2960101348 cites W2522550673 @default.
• W2960101348 cites W2547042202 @default.
• W2960101348 cites W2547295550 @default.
• W2960101348 cites W2579721738 @default.
• W2960101348 cites W2585024341 @default.
• W2960101348 cites W2590767446 @default.
• W2960101348 cites W2595820219 @default.
• W2960101348 cites W2601399872 @default.
• W2960101348 cites W2755621348 @default.
• W2960101348 cites W2765165142 @default.
• W2960101348 cites W2802043998 @default.
• W2960101348 cites W2805309778 @default.
• W2960101348 cites W2809492509 @default.
• W2960101348 cites W2809951886 @default.
• W2960101348 cites W2826739133 @default.
• W2960101348 cites W2895245324 @default.
• W2960101348 cites W2897323630 @default.
• W2960101348 cites W2901544838 @default.
• W2960101348 cites W2935657670 @default.
• W2960101348 doi "https://doi.org/10.1186/s12936-019-2864-1" @default.
• W2960101348 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6624891" @default.
• W2960101348 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31296223" @default.
• W2960101348 hasPublicationYear "2019" @default.
• W2960101348 type Work @default.
• W2960101348 sameAs 2960101348 @default.
• W2960101348 citedByCount "20" @default.
• W2960101348 countsByYear W29601013482020 @default.
• W2960101348 countsByYear W29601013482021 @default.
• W2960101348 countsByYear W29601013482022 @default.
• W2960101348 countsByYear W29601013482023 @default.
• W2960101348 crossrefType "journal-article" @default.
• W2960101348 hasAuthorship W2960101348A5012199507 @default.
• W2960101348 hasAuthorship W2960101348A5012720550 @default.
• W2960101348 hasAuthorship W2960101348A5014087860 @default.
• W2960101348 hasAuthorship W2960101348A5024691862 @default.
• W2960101348 hasAuthorship W2960101348A5032947745 @default.
• W2960101348 hasAuthorship W2960101348A5042879380 @default.
• W2960101348 hasAuthorship W2960101348A5042900357 @default.
• W2960101348 hasAuthorship W2960101348A5049427727 @default.
• W2960101348 hasAuthorship W2960101348A5054399462 @default.
• W2960101348 hasAuthorship W2960101348A5063837509 @default.
• W2960101348 hasAuthorship W2960101348A5064218236 @default.
• W2960101348 hasAuthorship W2960101348A5064797479 @default.
• W2960101348 hasAuthorship W2960101348A5070525052 @default.
• W2960101348 hasAuthorship W2960101348A5083456572 @default.
• W2960101348 hasAuthorship W2960101348A5089661257 @default.
• W2960101348 hasBestOaLocation W29601013481 @default.
• W2960101348 hasConcept C114851261 @default.
• W2960101348 hasConcept C126322002 @default.
• W2960101348 hasConcept C203014093 @default.
• W2960101348 hasConcept C2776120307 @default.
• W2960101348 hasConcept C2776999253 @default.
• W2960101348 hasConcept C2777616469 @default.
• W2960101348 hasConcept C2778048844 @default.

• next